1 / 5

Alsheikh-Ali AA et al Circulation. 2005; 111:3051

Demographic Characteristics of Individuals With AERS of Rhabdomyolysis, Proteinuria/Nephropathy, or Renal Failure (COMPOSITE AERS). Alsheikh-Ali AA et al Circulation. 2005; 111:3051.

maura
Download Presentation

Alsheikh-Ali AA et al Circulation. 2005; 111:3051

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Demographic Characteristics of Individuals With AERS of Rhabdomyolysis, Proteinuria/Nephropathy, or Renal Failure (COMPOSITE AERS) Alsheikh-Ali AA et al Circulation. 2005; 111:3051

  2. Rates of composite end point of AERs of rhabdomyolysis, proteinuria/nephropathy, or renal failure (COMPOSITE AERs) associated with various statins†P0.001 for pairwise comparison vs rosuvastatin Alsheikh-Ali AA et al Circulation. 2005; 111:3051

  3. Percent of Statin-Associated COMPOSITE AERS (of Rhabdomyolysis, Proteinuria/Nephropathy, or Renal Failure) Listing Concomitant Use of Other Drugs That Can Potentially Interact With Statins Alsheikh-Ali AA et al Circulation. 2005; 111:3051

  4. Rates of each category of AERs associated with various statins Alsheikh-Ali AA et al Circulation. 2005; 111:3051

  5. Rates of each category of AERs associated with various statins during respective first postmarketing year for each statin Alsheikh-Ali AA et al Circulation. 2005; 111:3051

More Related